EMA Dismisses Claims That RWD Is The ‘Wrong Remedy’ For Drug Development Challenges

The European Medicines Agency has responded to an analysis that argued that generating evidence for decision making in health care using observational real-world data, and thus potentially replacing randomized controlled trials, “is the wrong remedy for the challenges in drug development.”